Efficient drug development depends on in vitro ADME Tox lead optimization.
But what happens when drug-discovery companies skip this key drug-development step
and take their compounds directly to in vivo studies? Click on the "PLAY" pill
below to see the drug-development disaster that ensues.
Apredica's scientists have many years of drug discovery and drug development experience. They can guide
you through the appropriate ADME Tox and PK studies. Apredica's state-of-the-art
services and fast turn around times
will help you make your go/no-go decisions faster while reducing your total preclinical drug development costs.
Contact us to learn more about Apredica's ADME Tox services.